Experimental Design Approach for Quantitative Expressions of Simultaneous Quantification of Two Binary Formulations Containing Remogliflozin and Gliptins by RP-HPLC

Experimental Design Approach for Quantitative Expressions of Simultaneous Quantification of Two Binary Formulations Containing Remogliflozin and Gliptins by RP-HPLC

The aim of this study was to develop a fast RP-HPLC method for simultaneous measurement of two antidiabetic formulations (vildagliptin + remogliflozin and teneligliptin + remogliflozin) under identical experimental conditions. Using the Box–Behnken approach and response surface design, the interacti...

Full description

Bibliographic Details
Main Authors:	Mahesh Attimarad, Katharigatta Narayanaswamy Venugopala, Anroop Balachandran Nair, Nagaraja Sreeharsha, Pran Kishore Deb
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Separations
Subjects:	remogliflozin vildagliptin teneligliptin experimental design HPLC formulation
Online Access:	https://www.mdpi.com/2297-8739/9/2/23

Similar Items

Development of Ecofriendly Derivative Spectrophotometric Methods for the Simultaneous Quantitative Analysis of Remogliflozin and Vildagliptin from Formulation
by: Mahesh Attimarad, et al.
Published: (2021-10-01)

An Experimental Design Approach to Quantitative Expression for Quality Control of a Multicomponent Antidiabetic Formulation by the HILIC Method
by: Mahesh Attimarad, et al.
Published: (2022-05-01)

Development and Validation of Rapid RP-HPLC and Green Second-Derivative UV Spectroscopic Methods for Simultaneous Quantification of Metformin and Remogliflozin in Formulation Using Experimental Design
by: Mahesh Attimarad, et al.
Published: (2020-10-01)

In silico modified UV spectrophotometric approaches to resolve overlapped spectra for quality control of rosuvastatin and teneligliptin formulation
by: Attimarad Mahesh, et al.
Published: (2024-04-01)

A prospective, multicentre study evaluating safety and efficacy of a fixed dose combination of Remogliflozin etabonate, Vildagliptin, and Metformin in Indian patients with type 2 diabetes mellitus (Triad-RMV)
by: Prabhat K Agarwal, et al.
Published: (2024-12-01)

Is REmogliflozin an effective Drug in MANaging Type-2 diabetes mellitus: A comparative study – (REDMAN)
by: Prabhat Agrawal, et al.
Published: (2022-07-01)

Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
by: Yayoi Nishida, et al.
Published: (2020-04-01)

Correction: Development of UV spectrophotometry methods for concurrent quantification of amlodipine and celecoxib by manipulation of ratio spectra in pure and pharmaceutical formulation.
by: Mahesh Attimarad, et al.
Published: (2019-01-01)

Smart mathematically filtered UV spectroscopic methods for quality assurance of rosuvastatin and valsartan from formulation
by: Attimarad Mahesh, et al.
Published: (2024-10-01)

Multivariate Optimization of Chromatographic Conditions for Rapid Simultaneous Quantification of Antidiarrheal Drugs in Formulation Using Surface Response Methodology
by: Mahesh Attimarad, et al.
Published: (2022-04-01)

A Rapid HPLC Method for the Concurrent Determination of Several Antihypertensive Drugs from Binary and Ternary Formulations
by: Mahesh Attimarad, et al.
Published: (2021-06-01)

Development of UV Spectrophotometric Procedures for Determination of Amlodipine and Celecoxib in Formulation: Use of Scaling Factor to Improve the Sensitivity
by: Mahesh Attimarad, et al.
Published: (2019-01-01)

Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
by: Gagik Radikovich Galstyan, et al.
Published: (2015-12-01)

Progress Report: Antimicrobial Drug Discovery in the Resistance Era
by: Pottathil Shinu, et al.
Published: (2022-03-01)

QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)
by: Erande S, et al.
Published: (2019-06-01)

Novel RP-HPLC method for simultaneous determination of dapagliflozin and teneligliptin in tablet formulation and identification of degradation products by LC-MS/MS
by: Thummar Kashyap, et al.
Published: (2024-11-01)

Method operable design region for robust RP-HPLC analysis of pioglitazone hydrochloride and teneligliptin hydrobromide hydrate: incorporating hybrid principles of white analytical chemistry and design of experiments
by: Pintu Prajapati, et al.
Published: (2023-10-01)

Mathematically Processed UV Spectroscopic Method for Quantification of Chlorthalidone and Azelnidipine in Bulk and Formulation: Evaluation of Greenness and Whiteness
by: Mahesh Attimarad, et al.
Published: (2022-01-01)

Prescribing patterns in type 2 diabetes mellitus outpatients at a tertiary care centre in Jaipur, India
by: Dadhich Jaya, et al.
Published: (2022-01-01)

Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report
by: Serhat Sayin, et al.
Published: (2018-03-01)

EFFECT OF PHARMACOLOGICAL PRECONDITIONING WITH INCRETINOMIMETICS EXENATIDE AND VILDAGLIPTIN ON THE SURVIVAL OF ISCHEMIC TISSUES
by: Alla Tarasova, et al.
Published: (2017-12-01)

Monitoring of Non-β-Lactam Antibiotic Resistance-Associated Genes in ESBL Producing <i>Enterobacterales</i> Isolates
by: Pottathil Shinu, et al.
Published: (2020-12-01)

Design, Development, and Evaluation of Constant Voltage Iontophoresis for the Transungual Delivery of Efinaconazole
by: Anroop B. Nair, et al.
Published: (2023-05-01)

Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on therapy
by: Amit Kumar, et al.
Published: (2019-07-01)

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)
by: Ghosh S, et al.
Published: (2016-11-01)

The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Cost Utility Analysis Vildagliptin dan Glimepiride dalam Mencegah Komplikasi Mikrovaskuler menggunakan Model Markov
by: Tri Julia Purnamasari, et al.
Published: (2023-12-01)

UJI EFEKTIVITAS DAN KEAMANAN KOMBINASI METFORMIN-VILDAGLIPTIN PADA DIABETES MELITUS TIPE 2 DI RSPAL Dr. RAMELAN SURABAYA
by: Dwi Octamy Sari, et al.
Published: (2023-10-01)

Effect of vildagliptin on atherosclerosis progression in high cholesterol –fed male rabbits
by: Sahar A Majeed
Published: (2014-12-01)

Constant Voltage Iontophoresis Technique to Deliver Terbinafine via Transungual Delivery System: Formulation Optimization Using Box–Behnken Design and In Vitro Evaluation
by: Anroop B. Nair, et al.
Published: (2021-10-01)

Formulation and Evaluation of Self-Nanoemulsifying Drug Delivery System Derived Tablet Containing Sertraline
by: Anroop B. Nair, et al.
Published: (2022-01-01)

Efficacy and safety of teneligliptin in Indian patients with inadequately controlled Type 2 diabetes mellitus: A randomized, double-blind study
by: Piyush Agarwal, et al.
Published: (2018-01-01)

Intranasal Delivery of Darunavir-Loaded Mucoadhesive In Situ Gel: Experimental Design, In Vitro Evaluation, and Pharmacokinetic Studies
by: Anroop B. Nair, et al.
Published: (2022-05-01)

Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
by: Anroop B Nair, et al.
Published: (2021-01-01)

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2013-06-01)

A Randomized, Two-Treatments, Two-Periods, Crossover, Open label, Laboratory-Blind, Single Dose Bioequivalence Study between Vildagliptin/Metformin 50 mg/1000 mg Film Coated Tablets (Sensityn®) and Galvusmet® 50 mg/1000 mg Film Coated Tablets in healthy adults under fed conditions
by: Shiekmydeen J., et al.
Published: (2023-10-01)

Evaluation of Teneligliptin and Retagliptin on the Clearance of Melanosome by Melanophagy in B16F1 Cells
by: Seong Hyun Kim, et al.
Published: (2024-03-01)

Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin (CHAT-T)
by: Yosuke Takamiya, et al.
Published: (2020-04-01)

Design of Experimental Approach for Development of Rapid High Performance Liquid Chromatographic Process for Simultaneous Estimation of Metoprolol, Telmisartan, and Amlodipine from Formulation: Greenness and Whiteness Evaluation
by: Mahesh Attimarad, et al.
Published: (2024-02-01)

Exploration of the Antimicrobial Effects of Benzothiazolylthiazolidin-4-One and In Silico Mechanistic Investigation
by: Michelyne Haroun, et al.
Published: (2021-07-01)